Overview
- 7 inspections across 7 sites are on record.
- 12 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2010-03-09.
At a glance
Inspections
7
Sites
7
Observations
12
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Organon Pharma (UK) Ltd. | 9 Mar 2010 | ||
| Novartis Pharma Stein AG | 2 Mar 2010 | ||
| Delpharm Montreal Inc. | 7 Jul 2009 | ||
| BWXT Medical Ltd. | 30 Jun 2009 | On file | |
| Mixed Nuts Inc. | 7 Apr 2009 | View 483 → |
Sites inspected
Organon Pharma (UK) Ltd.Cramlington, United Kingdom1 insp.
Novartis Pharma Stein AGStein Ag, Switzerland1 insp.
Delpharm Montreal Inc.Pointe-Claire, Canada1 insp.
BWXT Medical Ltd.Ottawa, Canada1 insp.
Mixed Nuts Inc.Pico Rivera, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Bruce H Mccullough2 shared
Erin D Mccaffery2 shared
Jeremy Beber1 shared
Nabeela J Chaudhry1 shared
Comyar Shoghi1 shared
Sarah A Hassas1 shared
Jeffrey M Watson1 shared
Kevin P Foley1 shared
Henry K Lau1 shared
Full investigator report
Get the verbatim findings behind Mei-Chiung J Huang's 12 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site